|Title:||Topical steroid formulation in form of lotion or cream|
|Abstract:||Steroid formulations in the form of creams or lotions which are used as topical anti-inflammatory agents are provided wherein the steroid, such as 21-chloro-9.alpha.-fluoro-.DELTA..sup.4 -pregnene-11.beta.,16.alpha.,17.alpha.-triol-3,20-dione 16,17-acetonide, is at least partially dissolved in a ricinoleate vehicle such as castor oil.|
|Inventor(s):||Chen; James Ling (East Brunswick, NJ), Battaglia; Jean M. (North Brunswick, NJ)|
|Assignee:||E. R. Squibb & Sons, Inc. (Princeton, NJ)|
Patent Claim Types:|
see list of patent claims
|Composition; Formulation; Use;|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.